☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
MediLink Therapeutics
MediLink Therapeutics Enters into a Collaboration and License Agreement with Roche to Develop and Commercialize YL211 for Solid Tu...
January 3, 2024
MediLink Therapeutics Entered into a Collaboration and License Agreement with BioNTech to Develop Next-Generation Anti-Cancer Anti...
October 14, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.